The Rs 500-crore IPO of Tatva Chintan Pharma Chem is witnessing an overwhelming response from investors as it is oversubscribed by 19.16 times so far, on July 20, the final day of bidding.
Investors have put in bids for 6.24 crore equity shares against…
Tatva Chintan IPO subscribed 19 times on final day, retail portion booked 27 times
Share this article
More News
3DX and BridgePort Partner for Crypto Settlement
March 5, 2026
Why businesses should accept crypto as payment in 2026
March 5, 2026
